Blog
|
Discover Alan

Alan & Belfius : A strategic partnership to transform the healthcare sector

This unprecedented agreement enforces a shared vision to transform the healthcare sector by leveraging Alan's key differentiators: prevention, insurance, and daily care, driven by continuous innovation.

Alan & Belfius : A strategic partnership to transform the healthcare sector
Updated on
20 September 2024
Updated on
20 September 2024
Share this article
In this article

Alan & Belfius partnership

This marks a significant milestone in Alan's development in Belgium, offering its services to all of Belfius' corporate and institutional clients, representing millions of employees, starting today. Over time, Alan will also cover Belfius' 7,000 employees.

On this occasion, Alan is announcing a new Series F funding round of €173 million led by Belfius, with the participation of leading international investors, bringing its valuation to €4 billion.

This collaboration marks a major step in Alan’s growth in Belgium, its second-largest market after France in terms of activity. The partnership includes a distribution agreement, making Alan Belfius’ preferred partner for insurance and innovative health services, catering to the bank’s corporate, SME, and institutional clients.

To support this momentum, Alan plans to strengthen its local team by making more than 25 strategic hires in Belgium over the coming months.

Alan’s valuation reaches €4 billion

As part of this partnership, Alan is completing a Series F funding round of €173 million, led by Belfius, with renewed support from existing investors (OTPP via Teachers' Venture Growth, Temasek, Coatue, Lakestar), and numerous French and international major entrepreneurs.

While Alan maintains full control of its cash flow and confirms its objective to achieve group profitability by 2026, this investment will accelerate its growth, further enhance its technological lead, and intensify its international expansion. The company's governance remains unchanged, with the two founders and the employees being the largest shareholders, controlling over 40% of the capital and the majority of voting rights.

The joint commitment of Alan and Belfius to innovation

This alliance cements Alan's position as a pioneer in health insurance innovation and artificial intelligence. Through advanced AI tools, Alan will offer personalized services tailored to local needs, improving the customer experience, claims processing, and overall operational efficiency.

Jean-Charles Samuelian, CEO d'Alan et Marc Raisière, CEO de Belfius
Jean-Charles Samuelian, CEO d'Alan et Marc Raisière, CEO de Belfius

Jean-Charles Samuelian, CEO of Alan, states: “This privileged partnership with Belfius, whose transformation over the past decade has been truly inspiring, opens the door to a new era for Alan in Belgium. Belfius’ investment will allow us to accelerate our development and expand our capacity to offer cutting-edge, accessible health products and services to a wide audience. We would like to thank Marc Raisière, their CEO, and the entire team for their trust and commitment. We are confident that our shared vision—‘Love your people, boost your business’—will enable us to positively transform the healthcare system in Belgium.”

Marc Raisière, CEO of Belfius, adds: "At Belfius, we firmly believe in the power of European talent in artificial intelligence, their revolutionary potential for the banking and insurance industries, and for society as a whole. I am delighted to announce our strategic partnership with Alan, a healthcare pioneer in Europe. Together with Jean-Charles Samuelian and the Alan team, we are ushering in a new era of employee well-being and business success. By combining their cutting-edge technology with our commitment to innovation, we are investing in the peace of mind, productivity, and growth of everyone’s most precious asset: people. This is how we can bring meaning and inspiration to Belgian society, together.”

Published on 20/09/2024

On the same topic

Alan - 2024 Q2 Letter to Shareholders
Alan - 2024 Q2 Letter to Shareholders
Jul 29, 2024

All categories

Discover Alan

The future of health and well-being

Alan decrypts